Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy.
J Exp Clin Cancer Res. 2022 Oct 21;41(1):309. doi: 10.1186/s13046-022-02479-y.
J Exp Clin Cancer Res. 2022.
PMID: 36271379
Free PMC article.
Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody.
Modica C, Gallo S, Chiriaco C, Spilinga M, Comoglio PM, Crepaldi T, Basilico C, Vigna E.
Modica C, et al.
Cancers (Basel). 2020 Mar 21;12(3):741. doi: 10.3390/cancers12030741.
Cancers (Basel). 2020.
PMID: 32245152
Free PMC article.
Item in Clipboard
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers.
Martinelli I, Modica C, Chiriaco C, Basilico C, Hughes JM, Corso S, Giordano S, Comoglio PM, Vigna E.
Martinelli I, et al.
J Exp Clin Cancer Res. 2022 Mar 29;41(1):112. doi: 10.1186/s13046-022-02320-6.
J Exp Clin Cancer Res. 2022.
PMID: 35351166
Free PMC article.
Item in Clipboard
Cite
Cite